−11.61 MUSD
About Scopus Biopharma, Inc.
Sector
Headquarters
New York
Employees (FY)
13
Website
Founded
2017
ISIN
US8091711015
FIGI
BBG00PGSG3M7
Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of therapeutics targeting diseases with unmet medical needs. The company was founded on April 18, 2017 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SCPS is 0.0016 USD — it has decreased by 36.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Scopus Biopharma, Inc. stocks are traded under the ticker SCPS.
Scopus Biopharma, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
SCPS stock is 127.27% volatile and has beta coefficient of −5.66. Check out the list of the most volatile stocks — is Scopus Biopharma, Inc. there?
SCPS earnings for the last quarter are −0.97 USD per share, whereas the estimation was −0.23 USD resulting in a −321.74% surprise. The estimated earnings for the next quarter are −0.23 USD per share. See more details about Scopus Biopharma, Inc. earnings.
Yes, you can track Scopus Biopharma, Inc. financials in yearly and quarterly reports right on TradingView.
SCPS stock has fallen by 36.00% compared to the previous week, the month change is a 30.43% fall, over the last year Scopus Biopharma, Inc. has showed a 96.80% decrease.
No, SCPS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SCPS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Scopus Biopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 13.00 employees. See our rating of the largest employees — is Scopus Biopharma, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Scopus Biopharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Scopus Biopharma, Inc. stock shows the sell signal. See more of Scopus Biopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.